Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

3.27
-0.1500-4.39%
Post-market: 3.300.0300+0.92%18:43 EDT
Volume:3.44M
Turnover:11.39M
Market Cap:281.91M
PE:-0.87
High:3.46
Open:3.42
Low:3.25
Close:3.42
52wk High:19.11
52wk Low:3.25
Shares:86.21M
Float Shares:60.67M
Volume Ratio:1.38
T/O Rate:5.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:1.69
PE(LYR):-1.03

Loading ...

JonesTrading Sticks to Its Buy Rating for EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
Sep 28

These Beaten-Down Stocks Could Bounce Back in January, if History is Any Guide

Dow Jones
·
Sep 22

EyePoint Grants Inducement Stock Options for 3,000 Shares at $3.66 Each

Reuters
·
Sep 16

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 16

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

EyePoint Price Target Cut to $4.00/Share from $20.00 by TD Cowen

Dow Jones
·
Sep 02

TD Cowen Downgrades EyePoint Pharmaceuticals to Hold From Buy, Adjusts PT to $4 From $20

MT Newswires Live
·
Sep 02

EyePoint to Join Citi, Cantor and Morgan Stanley Healthcare Investor Conferences

Reuters
·
Sep 02

EyePoint downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Sep 02

U.S. Research Roundup-Adobe, Dell Technologies, Zscaler

Reuters
·
Sep 02

EyePoint Inc : TD Cowen Cuts to Hold from Buy; Cuts Target Price to $4 from $20

THOMSON REUTERS
·
Sep 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
Sep 02

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Sweden's SynAct Pharma Q2 Net Loss Narrows on Lower Expenses

Reuters
·
Aug 20

Analyst Maintains Buy on Duravyu, Cutting Price Target to $20 Amid LUCIA Trial Binary Risk

TIPRANKS
·
Aug 19

Iridex Q2 Revenue Falls as Retina Sales Decline

Reuters
·
Aug 19

EyePoint Director Karen Zaderej Reports Purchase of 10,600 Shares Worth $52,258

Reuters
·
Aug 19

EyePoint is Maintained at Buy by Citigroup

Dow Jones
·
Aug 19

EyePoint Faces Regulatory Uncertainty After Lugano Trial Miss, RBC Capital Markets Says

MT Newswires Live
·
Aug 18

U.S. Stocks on the MOVE-Dynatrace, Duolingo, Baidu Inc

Reuters
·
Aug 18